Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-4-7
pubmed:abstractText
Progression of coronary artery disease (CAD) after primary coronary artery bypass grafting (CABG) is frequent and may lead to recurrent symptoms. Various data indicate that apoptosis is the main event occurring during development and progression of atherosclerotic plaque. Plaque vascular smooth muscle cells (VSMCs) are more sensitive than regular VSMCs to TP53-mediated apoptosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1420-908X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
439-45
pubmed:meshHeading
pubmed-meshheading:21286777-Aged, pubmed-meshheading:21286777-Antigens, CD95, pubmed-meshheading:21286777-Apoptosis, pubmed-meshheading:21286777-Coronary Artery Bypass, pubmed-meshheading:21286777-Coronary Artery Disease, pubmed-meshheading:21286777-Disease Progression, pubmed-meshheading:21286777-Fas Ligand Protein, pubmed-meshheading:21286777-Female, pubmed-meshheading:21286777-Genes, p53, pubmed-meshheading:21286777-Humans, pubmed-meshheading:21286777-Male, pubmed-meshheading:21286777-Middle Aged, pubmed-meshheading:21286777-Polymorphism, Genetic, pubmed-meshheading:21286777-Polymorphism, Restriction Fragment Length, pubmed-meshheading:21286777-Promoter Regions, Genetic, pubmed-meshheading:21286777-Sequence Analysis, DNA, pubmed-meshheading:21286777-Treatment Outcome, pubmed-meshheading:21286777-Tumor Suppressor Protein p53
pubmed:year
2011
pubmed:articleTitle
Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view.
pubmed:affiliation
Department of Cardiac Surgery, Ludwig Maximilians University Munich, Marchioninistr. 15, 81366, Munich, Germany.
pubmed:publicationType
Journal Article